Stocks move big afternoon: DE, ABNB, AN, MRNA

Deere’s autonomous 8R tractor


Take a look at the companies that take the biggest steps in the afternoon:

Deere – Shares rose 7.7% after the company reported earnings per share of $6.55 for the fiscal first quarter, which was higher than the $5.57 expected by analysts polled by Refinitiv. The farm equipment maker’s revenue was $11.4 billion, versus the expected $11.28 billion.

Airbnb – Shares of the vacation rental company fell 5.3%, a day after rising 13.35% following a better-than-expected fourth-quarter earnings report. Some Wall Street analysts remained cautious on the stock, citing risks including competition and slower-than-expected consumer adoption of alternative accommodations.

Albemarle – The specialty chemicals company fell 10.3%, a day after gaining nearly 5%. Albemarle reported adjusted earnings per share after the bell Wednesday, as well as revenue in line with expectations, per StreetAccount.

Bio-Rad Laboratories – Shares rose 5.5% after the company reported fourth-quarter net profit of $827.7 million, following a year-earlier loss in the same period. The company’s non-operating margin also increased from 15.7% in the same period last year to 17.4%. Still, earnings and earnings missed Wall Street estimates.

Zebra Technologies — Shares fell 5.3% after the company forecast full-year sales to decline slightly. CEO Anders Gustafsson said he is taking a “cautious approach” to the outlook based on an uncertain macroeconomic environment. Zebra’s fourth-quarter earnings and revenue, however, beat Wall Street estimates.

AutoNation – Shares of the car dealership rose 9.4% after the company beat earnings and sales expectations for the fourth quarter. AutoNation reported adjusted earnings of $6.37 per share, versus Refinitiv’s estimate of $5.83. Sales of $6.7 billion surpassed the expected $6.52 billion.

DraftKings – Shares rose more than 14% after DraftKings reported fourth-quarter results that beat expectations. The sports betting company reported a loss of 53 cents per share on revenue of $855 million. Analysts polled by Refinitiv had expected a loss of 59 cents per share on revenue of $800 million.

Moderna – Biotech stock fell more than 4% after its flu vaccine candidate received mixed results in clinical trials.

Redfin – Shares fell 7.1% even after Redfin reported better-than-expected fourth-quarter results. The real estate company reported a loss of 57 cents per share on $480 million in revenue. Analysts predicted a loss of $1.08 per share on $445 million in revenue, according to consensus estimates from Refinitiv. Still, sales fell year on year.

Roku – Shares of the streaming device company erased early gains amid the broader sell-off on Wall Street. The stock first traded higher after Bank of America double upgraded the stock to buy from underperform as the Wall Street firm said Roku is on track for revenue and margin improvement. It was down 1.2% last time.

DoorDash – Shares of the food delivery company fell 7.2% after DoorDash reported a mixed fourth quarter. DoorDash reported $1.82 billion in revenue for the quarter, more than the $1.77 billion expected by Refinitiv, delivering an upbeat outlook. However, the company’s loss of $1.65 per share was more than twice what analysts had expected.

Biogen – Shares of the biopharmaceutical company rose 1.6% after Japanese drugmaker Eisai said it expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer. Eisai co-developed the drug with Biogen.

– CNBC’s Jesse Pound Yun Li and Sarah Min contributed to the reporting.


Leave a Reply

Your email address will not be published. Required fields are marked *